Prenuvo
Prenuvo is an Aging Diagnostics & Biomarkers company founded in 2018 and based in Redwood City, United States.
Prenuvo was founded in 2018 in Vancouver, Canada, by Andrew Lacy, its CEO, and radiologist Dr. Raj Attariwala, who had spent the preceding decade developing the whole-body MRI approach the company commercialized. It is headquartered in Redwood City, California, and lists 28 clinics across the US, Canada, the UK and Australia, including a London clinic opened in November 2025. Customers pay for focused or whole-body scans, add-ons such as an FDA-cleared AI body-composition report and a brain health assessment, and blood panels. Since March 23, 2026 it has also sold annual memberships priced from $1,199 to $3,999. Employers and partners such as Parsley Health and Baker Health offer its scans to their members. Prenuvo raised a $70 million Series A led by Felicis in October 2022 and in February 2025 disclosed a $120 million Series B co-led by Forerunner Ventures and Left Lane Capital. By September 2026 it had performed more than 200,000 whole-body MRI scans.
Prenuvo runs a dedicated clinic network for radiation-free whole-body MRI, the screening that preventive-health memberships sell. Its biobank of more than 200,000 scans underpins the Prenuvo Research Network, launched Sept. 29, 2026 with collaborators from more than 50 institutions, including UCSF, City of Hope and Moffitt Cancer Center. Its March 2026 memberships pair yearly scans with lab panels, and partners such as Parsley Health and Baker Health bundle its scans into their programs.
At a glance
Total raised
Undisclosed
Headcount
—
Headquarters
Redwood City
United StatesFounded
2018
Status
Private
Subsector
Longevity, ranked
Top 25 Longevity companies →Funding history
Total raised
—
Rounds tracked
1
Latest stage
Series B
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Feb 13, 2025 | Series B | $120M | — | Forerunner Ventures, Left Lane Capital |
